MedTrace Logo

Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients

NCT04247464 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-10-05

No results posted yet for this study

Summary

This study will evaluate the ability of short-term fasting to reduce chemotherapy toxicity and enhance anti-tumour response in patients with colorectal carcinoma subjected to chemotherapy.

Conditions

  • Fasting

Interventions

PROCEDURE

Fasting

Food intake restriction

Sponsors & Collaborators

  • Hospital Infanta Sofia

    collaborator OTHER

  • Hospital Universitario La Paz

    collaborator OTHER

  • IMDEA Food

    lead OTHER

Principal Investigators

  • Enrique Casado, MD · Hospital Universitario Infanta Sofia

  • Francisco Zambrana, MD · Hospital Universitario Infanta Sofia

  • Pablo J Fernandez-Marcos, PhD · IMDEA Food

  • Jaime Feliu, MD · Hospital Universitario La Paz

  • Nuria Rodríguez-Salas, MD · Hospital Universitario La Paz

  • Ismael Ghanem- Cañete, MD · Hospital Universitario La Paz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-23
Primary Completion
2023-02-01
Completion
2023-02-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04247464 on ClinicalTrials.gov